HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
Looking ahead – what's ahead for healthcare tech and finance in 2023?
Finance/RCM

Looking ahead – what's ahead for healthcare tech and finance in 2023?

32:10

Editors from Healthcare IT News, MobiHealthNews and Healthcare Finance News sit down for a discussion about what the new year might hold.

Read More
Read Less

Finance/RCM - Similar Videos View more in Finance/RCM

13:49

Is MENA healthcare outgrowing the EMR?

MENA-based healthcare organizations are creating fully connected digital ecosystems and shifting to value-based care. Because of this, Mazin Gadir of Alvarez & Marsal says basic EMRs are no longer enough for these health systems.

Is MENA healthcare outgrowing the EMR?
MENA-based healthcare organizations are creating fully connected digital ecosystems and shifting to value-based care. Because of this, Mazin Gadir of Alvarez & Marsal says basic EMRs are no longer enough for these health systems.
13:49
6:18

Preparing for the new Medicare prior auth model

Providers in six states face new financial risks and training burdens under mandatory WISeR review, which leverages machine learning to control costs and expedite care. It's going to be "a steep learning curve," says Jeff Ladner, CPO at Onspring.

Preparing for the new Medicare prior auth model
Providers in six states face new financial risks and training burdens under mandatory WISeR review, which leverages machine learning to control costs and expedite care. It's going to be "a steep learning curve," says Jeff Ladner, CPO at Onspring.
6:18
7:52

AI is driving down clinical denial rates

Todd Van Meter, CEO of Accuity, says that when partnering with clients, initial clinical denial rates are nearly cut in half and following an appeals process using an AI-driven platform, the final denial rates end up at 1% to 1.5%.

AI is driving down clinical denial rates
Todd Van Meter, CEO of Accuity, says that when partnering with clients, initial clinical denial rates are nearly cut in half and following an appeals process using an AI-driven platform, the final denial rates end up at 1% to 1.5%.
7:52